[The effect of a periovulatory prolactin imbalance on prolactin receptor expression in rat ovary cell].
Using the technique of immunohistochemistry in combination with cytophotometry, we have studied the effect of periovulatory hyper- and hypoprolactinemia on the expression of prolactin receptors in various cell types of rat ovaries during early estrus. It has been shown that intense specific staining of oocytes is positively controlled by prolactin. The maximal intensity of specific staining was found in cells of the cumulus and the inner layer of granulosa cells in mature follicles; staining intensity gradually diminished towards the outer boundary cell layer. Postovulatory follicles are distinct from those mature follicles in which there was no ovulation in their more intense manifestation of prolactin receptors in cells of the inner layer and cumulus, as well as in increased positive staining (after prolactin administration) only in the granulosa layer cells closest to theca. In follicles which did not ovulate by the time of the early estrus, prolactin administration leads to a proportional growth of specific immunoreactivity in all cell layers of the granulosa. The administration of bromocryptin, an inhibitor of prolactin secretion, leading to a 10-fold decrease in prolactin level in blood, results in a twofold decrease in the intensity of specific staining of all cell layers of the granulosa in either type of follicle. Corpora lutea of the previous cycle have irregularly positioned luteocytes with weak and strong specific staining, the intensity of which is not changed in response to prolactin and diminishes slightly after the administration of bromocryptin. We conclude that the most intense changes in the content of prolactin receptors under the conditions of imbalance of this hormone during the periovulatory period are observed in those follicles where the oocyte did not ovulate by the time of early estrus.
Kotok
T
T
Hebrew University of Jerusalem, Israel.
Bogorad
R L
RL
Smirnov
A N
AN
Turovetskiĭ
V M
VM
Smirnova
O V
OV
D000818:Animals; D001971:Bromocriptine / Q000494:pharmacology; D003592:Cytophotometry; D004971:Estrus / Q000187:drug effects / Q000502:physiology; D005260:Female; D006727:Hormone Antagonists / Q000494:pharmacology; D006966:Hyperprolactinemia / Q000378:metabolism*; D007150:Immunohistochemistry; D010053:Ovary / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D010060:Ovulation / Q000187:drug effects / Q000502:physiology*; D011388:Prolactin / Q000037:antagonists & inhibitors / Q000172:deficiency*; D051381:Rats; D011981:Receptors, Prolactin / Q000187:drug effects / Q000378:metabolism*; D018709:Statistics, Nonparametric
D006727:Hormone Antagonists; D011981:Receptors, Prolactin; D001971:Bromocriptine; D011388:Prolactin